Table 1.
Descriptive statistics for breast cancer (BC) patients and age-matched controls.
| All women (N = 233) | BC patients (N = 106) | Age-matched controls (N = 127) | Value of p | |
|---|---|---|---|---|
| Age (M + SD) | 53.02 (10.63) | 53.69 (8.78) | 52.46 (11.96) | 0.687 |
| Years of education (M + SD) | 15.02 (4.13) | 13.96 (4.13) | 15.90 (3.93) | <0.001 |
| Comorbidities | 0.373 | |||
| Yes (%) | 92 (39%) | 41(39%) | 42 (33%) | |
| No (%) | 144 (61%) | 65 (61%) | 85 (67%) | |
| Currently working | 0.409 | |||
| Yes (%) | 93 (39%) | 62 (58%) | 81 (64%) | |
| No (%) | 143 (61%) | 44 (42%) | 46 (36%) | |
| Subjective cognitive complaints (SCC) | <0.001 | |||
| Yes (%) | 60 (26%) | 39 (37%) | 21 (17%) | |
| No (%) | 173 (74%) | 67 (63%) | 106 (83%) | |
| Number of adjuvant therapies | ||||
| 1 (%) | 34 (32%) | – | ||
| 2 (%) | 39 (37%) | – | ||
| 3 or more (%) | 33 (31%) | – | ||
| Status of adjuvant treatment | ||||
| Ongoing (%) | 47 (44%) | – | ||
| Ended (%) | 59 (56%) | – | ||
| Type of therapy still ongoing | ||||
| Chemotherapy (alone or + other*) | 37 (79%) | – | ||
| Other* | 10 (21%) | – | ||
| Time from start of adjuvant treatment | ||||
| ≤1 year (%) | 30 (28%) | – | ||
| >1 year (%) | 76 (72%) | – | ||
| Time from conclusion of adjuvant treatment | ||||
| ≤1 year (%) | 12 (11%) | – | ||
| >1 year (%) | 30 (28%) | – | ||
| >3 years (%) | 19 (17%) | – | ||
| Type of adjuvant treatment | ||||
| Chemotherapy (alone or + other) | 80 (75%) | – | ||
| Other* | 27 (25%) | – |
M, mean; SD, standard deviation. *Other types of therapies: radiation therapy, hormonal therapy, biological therapy, or combination.